The clinical significance of hepatocyte growth factor for non-small cell lung cancer - Discussion

被引：0
|
作者：
Patterson, GA
Siegfried
Benfield, JR
机构：
来源：
ANNALS OF THORACIC SURGERY | 1998年 / 66卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1918 / 1918
页数：1
相关论文
共 50 条
  • [1] The clinical significance of hepatocyte growth factor for non-small cell lung cancer
    Siegfried, JM
    Weissfeld, LA
    Luketich, JD
    Weyant, RJ
    Gubish, CT
    Landreneau, RJ
    ANNALS OF THORACIC SURGERY, 1998, 66 (06): : 1915 - 1918
  • [2] The pulmonary source of hepatocyte growth factor in non-small cell lung cancer
    Chow, Kuan-Chih
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2007, 36 (01) : 131 - 132
  • [3] Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer
    Tsuji, Takahiro
    Ozasa, Hiroaki
    Sakamori, Yuichi
    Nomizo, Takashi
    Funazo, Tomoko
    Yasuda, Yuto
    Yoshida, Hironori
    Nagai, Hiroki
    Kim, Young Hak
    CANCER RESEARCH, 2017, 77
  • [4] Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer
    Tsuji, Takahiro
    Sakamori, Yuichi
    Ozasa, Hiroaki
    Yagi, Yoshitaka
    Ajimizu, Hitomi
    Yasuda, Yuto
    Funazo, Tomoko
    Nomizo, Takashi
    Yoshida, Hironori
    Nagai, Hiroki
    Maeno, Ken
    Oguri, Tetsuya
    Hirai, Toyohiro
    Kim, Young Hak
    ONCOTARGET, 2017, 8 (42) : 71805 - 71816
  • [5] Expression of placenta growth factor (PIGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance
    Zhang L.
    Chen J.
    Ke Y.
    Mansel R.E.
    Jiang W.G.
    World Journal of Surgical Oncology, 3 (1)
  • [6] EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND BASIC FIBROBLAST GROWTH FACTOR IN HUMAN NON-SMALL CELL LUNG CANCER AND THEIR CLINICAL SIGNIFICANCE
    张伟
    王洁
    刘叙仪
    王曾礼
    张毅
    刘元林
    蒋薇
    Chinese Journal of Cancer Research, 2002, (04) : 28 - 33
  • [7] Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinib
    Masago, Katsuhiro
    Togashi, Yosuke
    Fujita, Shiro
    Sakamori, Yuichi
    Okuda, Chiyuki
    Kim, Young Hak
    Mio, Tadashi
    Mishima, Michiaki
    MEDICAL ONCOLOGY, 2012, 29 (03) : 1614 - 1621
  • [8] Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinib
    Katsuhiro Masago
    Yosuke Togashi
    Shiro Fujita
    Yuichi Sakamori
    Chiyuki Okuda
    Young Hak Kim
    Tadashi Mio
    Michiaki Mishima
    Medical Oncology, 2012, 29 : 1614 - 1621
  • [9] Clinical significance of serum hepatocyte growth factor (sHGF) in patients with advanced non-small-cell lung cancer (NSCLC).
    Tsuji, Takahiro
    Sakamori, Yuichi
    Ozasa, Hiroaki
    Ajimizu, Hitomi
    Yagi, Yoshitaka
    Nagai, Hiroki
    Mishima, Michiaki
    Kim, Young Hak
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer
    Siegfried, JM
    Weissfeld, LA
    SinghKaw, P
    Weyant, RJ
    Testa, JR
    Landreneau, RJ
    CANCER RESEARCH, 1997, 57 (03) : 433 - 439
12345